Filing Flows › Comparisons › INCY vs MEDP
Incyte vs Medpace Holdings: INCY and MEDP compared
Incyte is the larger company: $1.6B of revenue in its latest quarter (Q3 2026) against $716M for Medpace Holdings (Q3 2026). Incyte is growing faster (+14% against +8% a year earlier). Medpace Holdings is more profitable, with an operating margin of 23.1% against -45.5%.
Where the money goes: INCY and MEDP
Incyte (INCY) · Q3 2026
Incyte, Q3 2026: revenue $1.6B (+14% year over year), operating margin -45.5%, net loss $785M, operating cash flow −$675M. The chart follows the revenue to costs, profit and cash.
Medpace Holdings (MEDP) · Q3 2026
Medpace Holdings, Q3 2026: revenue $716M (+8% year over year), operating margin 23.1%, net earnings $137M, operating cash flow $217M. The chart follows the revenue to costs, profit and cash.
| Incyte (INCY) | Medpace Holdings (MEDP) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $1.6B | $716M |
| Revenue growth, Y/Y | +14% | +8% |
| Operating margin | -45.5% | 23.1% |
| Net earnings | −$785M | $137M |
| Net margin | -50.4% | 19.2% |
| Operating cash flow | −$675M | $217M |
| Free cash flow | — | $196M |
| Market value | $24.2B | $18.5B |
| P/E | 63.5× | 36.2× |
| Analysts’ mean target | $131.50 | $651.31 |
Where the revenue comes from
Incyte
- Net sales: $1.3B (85%)
- NIKTIMVO: $67.4M (4%)
- ZYNYZ: $58.3M (4%)
- OLUMIANT: $39.1M (3%)
Medpace Holdings
- Metabolic: $230M (32%)
- Other: $209M (29%)
- Oncology: $100M (14%)
- Cardiology: $83.6M (12%)
Questions
Which is bigger, Incyte or Medpace Holdings?
Incyte is the larger company: $1.6B of revenue in its latest quarter (Q3 2026) against $716M for Medpace Holdings (Q3 2026).
Is Incyte or Medpace Holdings growing faster?
Incyte is growing faster (+14% against +8% a year earlier).
Which is more profitable, Incyte or Medpace Holdings?
Medpace Holdings is more profitable, with an operating margin of 23.1% against -45.5%.
More: Incyte earnings · how Incyte makes money · Medpace Holdings earnings · how Medpace Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 29, 2026; 10-Q filed Oct 22, 2026). Fiscal quarters can end on different dates. Not investment advice.